Comparison of daily means over the entire follow-up period of progression in itens of the BATES-JENSEN scale.
traumatic, fractures, Martimbianco ALC, RA, injuries, PVD
MAY, ALMEIDA, PVD
* Clinical outcomes of the study: Jana Neto FC, Martimbianco ALC, Mesquita-Ferrari RA, Bussadori SK, Alves GP, Almeida PVD, et al. Effects of multiwavelength photobiomodulation for the treatment of traumatic soft tissue injuries associated with bone fractures: A double-blind, randomized controlled clinical trial. J Biophotonics. 2023 May 1;16 (19).The average duration of follow-up for the participants was 13.1 days (±11.5) in the PBM group and 23.1 days (±21.3) in the Control group. Nevertheless, this difference was not statistically significant between the two groups (p = 0.76), as already reported [The total cost of treatment for the Control group was R$21,164.56, and a difference of R$7,527.10 more was observed when compared to the treatment of the PBM group. For the first analysis, the mean daily score of the BATES-JENSEN scale was considered the outcome measure. When calculating the cost-effectiveness ratio based on the daily average in the scale scores, it was observed that the cost-effectiveness ratio of the PBM group was lower; that is, R$424.71 were spent in the PBM group for each point reduced on average per day in the BATES-JENSEN scale. The cost-effectiveness ratio compared to the two groups was R$3,500.98 (negative). In addition to the difference observed in the clinical trial outcome, when considering this crude analysis, the PBM group was more cost-effective (spent less with the lower daily average on the scale). In a second economic analysis, the outcome was "wound resolution time" measured in days (